カテゴリー： Market Monitor Global, 世界, 医療/バイオ

生殖補助医療用薬剤の世界市場見通し2023年-2029年

◆英語タイトル：Assisted Reproduction Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5696）

◆商品コード：MMG23JU5696
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：62
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Assisted Reproduction Drug Market 調査レポートは次の情報を含め、グローバルにおけるの生殖補助医療用薬剤市場規模と予測を収録しています。・世界の生殖補助医療用薬剤市場：売上、2018年-2023年、2024年-2029年
・世界の生殖補助医療用薬剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の生殖補助医療用薬剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ゴナドトロピン放出ホルモン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

生殖補助医療用薬剤のグローバル主要企業は、Merck Serono、 Merck Sharp & Dohme、 Livzon Group、 Zhejiang Xianju Pharmaceutical Co., Ltd.、 GenSci、 Shanghai First Biochemical Pharmaceutical Co. LTD、 Ipsen Pharma Biotech、 Solvay Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、生殖補助医療用薬剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の生殖補助医療用薬剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の生殖補助医療用薬剤市場：タイプ別市場シェア、2022年
・ゴナドトロピン放出ホルモン、卵胞刺激ホルモン、ヒトコロイック性ゴナドトロピン、プロゲストーゲンホルモン

世界の生殖補助医療用薬剤市場：用途別、2018年-2023年、2024年-2029年
世界の生殖補助医療用薬剤市場：用途別市場シェア、2022年
・ダウンレギュレーション、制御卵巣過剰刺激、排卵誘発、黄体サポート

世界の生殖補助医療用薬剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の生殖補助医療用薬剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における生殖補助医療用薬剤のグローバル売上、2018年-2023年
・主要企業における生殖補助医療用薬剤のグローバル売上シェア、2022年
・主要企業における生殖補助医療用薬剤のグローバル販売量、2018年-2023年
・主要企業における生殖補助医療用薬剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Merck Serono、 Merck Sharp & Dohme、 Livzon Group、 Zhejiang Xianju Pharmaceutical Co., Ltd.、 GenSci、 Shanghai First Biochemical Pharmaceutical Co. LTD、 Ipsen Pharma Biotech、 Solvay Pharma

*************************************************************

・調査・分析レポートの概要
生殖補助医療用薬剤市場の定義
市場セグメント
世界の生殖補助医療用薬剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の生殖補助医療用薬剤市場規模
世界の生殖補助医療用薬剤市場規模：2022年 VS 2029年
世界の生殖補助医療用薬剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの生殖補助医療用薬剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の生殖補助医療用薬剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ゴナドトロピン放出ホルモン、卵胞刺激ホルモン、ヒトコロイック性ゴナドトロピン、プロゲストーゲンホルモン
生殖補助医療用薬剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：ダウンレギュレーション、制御卵巣過剰刺激、排卵誘発、黄体サポート
生殖補助医療用薬剤の用途別グローバル売上・予測

・地域別市場分析
地域別生殖補助医療用薬剤市場規模 2022年と2029年
地域別生殖補助医療用薬剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck Serono、 Merck Sharp & Dohme、 Livzon Group、 Zhejiang Xianju Pharmaceutical Co., Ltd.、 GenSci、 Shanghai First Biochemical Pharmaceutical Co. LTD、 Ipsen Pharma Biotech、 Solvay Pharma
...

This report aims to provide a comprehensive presentation of the global market for Assisted Reproduction Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproduction Drug. This report contains market size and forecasts of Assisted Reproduction Drug in global, including the following market information:
Global Assisted Reproduction Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Assisted Reproduction Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Gonadotropin Releasing Hormone Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Assisted Reproduction Drug include Merck Serono, Merck Sharp & Dohme, Livzon Group, Zhejiang Xianju Pharmaceutical Co., Ltd., GenSci, Shanghai First Biochemical Pharmaceutical Co. LTD, Ipsen Pharma Biotech and Solvay Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Assisted Reproduction Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Assisted Reproduction Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Assisted Reproduction Drug Market Segment Percentages, by Type, 2022 (%)
Gonadotropin Releasing Hormone
Follicle-stimulating Hormone
Human Choroinic Gonadotrophin
Progestogen Hormone
Global Assisted Reproduction Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Assisted Reproduction Drug Market Segment Percentages, by Application, 2022 (%)
Down Regultion
Controlled Ovarian Hyperstimulation
Induced Ovulation
luteal Support
Global Assisted Reproduction Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Assisted Reproduction Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Assisted Reproduction Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Assisted Reproduction Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck Serono
Merck Sharp & Dohme
Livzon Group
Zhejiang Xianju Pharmaceutical Co., Ltd.
GenSci
Shanghai First Biochemical Pharmaceutical Co. LTD
Ipsen Pharma Biotech
Solvay Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Assisted Reproduction Drug, market overview.
Chapter 2: Global Assisted Reproduction Drug market size in revenue.
Chapter 3: Detailed analysis of Assisted Reproduction Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Assisted Reproduction Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Assisted Reproduction Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Assisted Reproduction Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Assisted Reproduction Drug Overall Market Size
2.1 Global Assisted Reproduction Drug Market Size: 2022 VS 2029
2.2 Global Assisted Reproduction Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Assisted Reproduction Drug Players in Global Market
3.2 Top Global Assisted Reproduction Drug Companies Ranked by Revenue
3.3 Global Assisted Reproduction Drug Revenue by Companies
3.4 Top 3 and Top 5 Assisted Reproduction Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Assisted Reproduction Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Assisted Reproduction Drug Players in Global Market
3.6.1 List of Global Tier 1 Assisted Reproduction Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Assisted Reproduction Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Assisted Reproduction Drug Market Size Markets, 2022 & 2029
4.1.2 Gonadotropin Releasing Hormone
4.1.3 Follicle-stimulating Hormone
4.1.4 Human Choroinic Gonadotrophin
4.1.5 Progestogen Hormone
4.2 By Type – Global Assisted Reproduction Drug Revenue & Forecasts
4.2.1 By Type – Global Assisted Reproduction Drug Revenue, 2018-2023
4.2.2 By Type – Global Assisted Reproduction Drug Revenue, 2024-2029
4.2.3 By Type – Global Assisted Reproduction Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Assisted Reproduction Drug Market Size, 2022 & 2029
5.1.2 Down Regultion
5.1.3 Controlled Ovarian Hyperstimulation
5.1.4 Induced Ovulation
5.1.5 luteal Support
5.2 By Application – Global Assisted Reproduction Drug Revenue & Forecasts
5.2.1 By Application – Global Assisted Reproduction Drug Revenue, 2018-2023
5.2.2 By Application – Global Assisted Reproduction Drug Revenue, 2024-2029
5.2.3 By Application – Global Assisted Reproduction Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Assisted Reproduction Drug Market Size, 2022 & 2029
6.2 By Region – Global Assisted Reproduction Drug Revenue & Forecasts
6.2.1 By Region – Global Assisted Reproduction Drug Revenue, 2018-2023
6.2.2 By Region – Global Assisted Reproduction Drug Revenue, 2024-2029
6.2.3 By Region – Global Assisted Reproduction Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Assisted Reproduction Drug Revenue, 2018-2029
6.3.2 US Assisted Reproduction Drug Market Size, 2018-2029
6.3.3 Canada Assisted Reproduction Drug Market Size, 2018-2029
6.3.4 Mexico Assisted Reproduction Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Assisted Reproduction Drug Revenue, 2018-2029
6.4.2 Germany Assisted Reproduction Drug Market Size, 2018-2029
6.4.3 France Assisted Reproduction Drug Market Size, 2018-2029
6.4.4 U.K. Assisted Reproduction Drug Market Size, 2018-2029
6.4.5 Italy Assisted Reproduction Drug Market Size, 2018-2029
6.4.6 Russia Assisted Reproduction Drug Market Size, 2018-2029
6.4.7 Nordic Countries Assisted Reproduction Drug Market Size, 2018-2029
6.4.8 Benelux Assisted Reproduction Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Assisted Reproduction Drug Revenue, 2018-2029
6.5.2 China Assisted Reproduction Drug Market Size, 2018-2029
6.5.3 Japan Assisted Reproduction Drug Market Size, 2018-2029
6.5.4 South Korea Assisted Reproduction Drug Market Size, 2018-2029
6.5.5 Southeast Asia Assisted Reproduction Drug Market Size, 2018-2029
6.5.6 India Assisted Reproduction Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Assisted Reproduction Drug Revenue, 2018-2029
6.6.2 Brazil Assisted Reproduction Drug Market Size, 2018-2029
6.6.3 Argentina Assisted Reproduction Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Assisted Reproduction Drug Revenue, 2018-2029
6.7.2 Turkey Assisted Reproduction Drug Market Size, 2018-2029
6.7.3 Israel Assisted Reproduction Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Assisted Reproduction Drug Market Size, 2018-2029
6.7.5 UAE Assisted Reproduction Drug Market Size, 2018-2029
7 Assisted Reproduction Drug Companies Profiles
7.1 Merck Serono
7.1.1 Merck Serono Company Summary
7.1.2 Merck Serono Business Overview
7.1.3 Merck Serono Assisted Reproduction Drug Major Product Offerings
7.1.4 Merck Serono Assisted Reproduction Drug Revenue in Global Market (2018-2023)
7.1.5 Merck Serono Key News & Latest Developments
7.2 Merck Sharp & Dohme
7.2.1 Merck Sharp & Dohme Company Summary
7.2.2 Merck Sharp & Dohme Business Overview
7.2.3 Merck Sharp & Dohme Assisted Reproduction Drug Major Product Offerings
7.2.4 Merck Sharp & Dohme Assisted Reproduction Drug Revenue in Global Market (2018-2023)
7.2.5 Merck Sharp & Dohme Key News & Latest Developments
7.3 Livzon Group
7.3.1 Livzon Group Company Summary
7.3.2 Livzon Group Business Overview
7.3.3 Livzon Group Assisted Reproduction Drug Major Product Offerings
7.3.4 Livzon Group Assisted Reproduction Drug Revenue in Global Market (2018-2023)
7.3.5 Livzon Group Key News & Latest Developments
7.4 Zhejiang Xianju Pharmaceutical Co., Ltd.
7.4.1 Zhejiang Xianju Pharmaceutical Co., Ltd. Company Summary
7.4.2 Zhejiang Xianju Pharmaceutical Co., Ltd. Business Overview
7.4.3 Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Major Product Offerings
7.4.4 Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Revenue in Global Market (2018-2023)
7.4.5 Zhejiang Xianju Pharmaceutical Co., Ltd. Key News & Latest Developments
7.5 GenSci
7.5.1 GenSci Company Summary
7.5.2 GenSci Business Overview
7.5.3 GenSci Assisted Reproduction Drug Major Product Offerings
7.5.4 GenSci Assisted Reproduction Drug Revenue in Global Market (2018-2023)
7.5.5 GenSci Key News & Latest Developments
7.6 Shanghai First Biochemical Pharmaceutical Co. LTD
7.6.1 Shanghai First Biochemical Pharmaceutical Co. LTD Company Summary
7.6.2 Shanghai First Biochemical Pharmaceutical Co. LTD Business Overview
7.6.3 Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Major Product Offerings
7.6.4 Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Revenue in Global Market (2018-2023)
7.6.5 Shanghai First Biochemical Pharmaceutical Co. LTD Key News & Latest Developments
7.7 Ipsen Pharma Biotech
7.7.1 Ipsen Pharma Biotech Company Summary
7.7.2 Ipsen Pharma Biotech Business Overview
7.7.3 Ipsen Pharma Biotech Assisted Reproduction Drug Major Product Offerings
7.7.4 Ipsen Pharma Biotech Assisted Reproduction Drug Revenue in Global Market (2018-2023)
7.7.5 Ipsen Pharma Biotech Key News & Latest Developments
7.8 Solvay Pharma
7.8.1 Solvay Pharma Company Summary
7.8.2 Solvay Pharma Business Overview
7.8.3 Solvay Pharma Assisted Reproduction Drug Major Product Offerings
7.8.4 Solvay Pharma Assisted Reproduction Drug Revenue in Global Market (2018-2023)
7.8.5 Solvay Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Assisted Reproduction Drug Market Opportunities & Trends in Global Market
Table 2. Assisted Reproduction Drug Market Drivers in Global Market
Table 3. Assisted Reproduction Drug Market Restraints in Global Market
Table 4. Key Players of Assisted Reproduction Drug in Global Market
Table 5. Top Assisted Reproduction Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Assisted Reproduction Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Assisted Reproduction Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Assisted Reproduction Drug Product Type
Table 9. List of Global Tier 1 Assisted Reproduction Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Assisted Reproduction Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Assisted Reproduction Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Assisted Reproduction Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Assisted Reproduction Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Assisted Reproduction Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Assisted Reproduction Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Assisted Reproduction Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Assisted Reproduction Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Assisted Reproduction Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Assisted Reproduction Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Assisted Reproduction Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Assisted Reproduction Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Assisted Reproduction Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Assisted Reproduction Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Assisted Reproduction Drug Revenue, (US$, Mn), 2024-2029
Table 30. Merck Serono Company Summary
Table 31. Merck Serono Assisted Reproduction Drug Product Offerings
Table 32. Merck Serono Assisted Reproduction Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Serono Key News & Latest Developments
Table 34. Merck Sharp & Dohme Company Summary
Table 35. Merck Sharp & Dohme Assisted Reproduction Drug Product Offerings
Table 36. Merck Sharp & Dohme Assisted Reproduction Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Sharp & Dohme Key News & Latest Developments
Table 38. Livzon Group Company Summary
Table 39. Livzon Group Assisted Reproduction Drug Product Offerings
Table 40. Livzon Group Assisted Reproduction Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Livzon Group Key News & Latest Developments
Table 42. Zhejiang Xianju Pharmaceutical Co., Ltd. Company Summary
Table 43. Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Product Offerings
Table 44. Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Zhejiang Xianju Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 46. GenSci Company Summary
Table 47. GenSci Assisted Reproduction Drug Product Offerings
Table 48. GenSci Assisted Reproduction Drug Revenue (US$, Mn) & (2018-2023)
Table 49. GenSci Key News & Latest Developments
Table 50. Shanghai First Biochemical Pharmaceutical Co. LTD Company Summary
Table 51. Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Product Offerings
Table 52. Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Shanghai First Biochemical Pharmaceutical Co. LTD Key News & Latest Developments
Table 54. Ipsen Pharma Biotech Company Summary
Table 55. Ipsen Pharma Biotech Assisted Reproduction Drug Product Offerings
Table 56. Ipsen Pharma Biotech Assisted Reproduction Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Ipsen Pharma Biotech Key News & Latest Developments
Table 58. Solvay Pharma Company Summary
Table 59. Solvay Pharma Assisted Reproduction Drug Product Offerings
Table 60. Solvay Pharma Assisted Reproduction Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Solvay Pharma Key News & Latest Developments
List of Figures
Figure 1. Assisted Reproduction Drug Segment by Type in 2022
Figure 2. Assisted Reproduction Drug Segment by Application in 2022
Figure 3. Global Assisted Reproduction Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Assisted Reproduction Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Assisted Reproduction Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Assisted Reproduction Drug Revenue in 2022
Figure 8. By Type - Global Assisted Reproduction Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Assisted Reproduction Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Assisted Reproduction Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Assisted Reproduction Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Assisted Reproduction Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Assisted Reproduction Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Assisted Reproduction Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Assisted Reproduction Drug Revenue Market Share, 2018-2029
Figure 16. US Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Assisted Reproduction Drug Revenue Market Share, 2018-2029
Figure 20. Germany Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Assisted Reproduction Drug Revenue Market Share, 2018-2029
Figure 28. China Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Assisted Reproduction Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Assisted Reproduction Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Assisted Reproduction Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Merck Serono Assisted Reproduction Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Sharp & Dohme Assisted Reproduction Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Livzon Group Assisted Reproduction Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GenSci Assisted Reproduction Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Ipsen Pharma Biotech Assisted Reproduction Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Solvay Pharma Assisted Reproduction Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 生殖補助医療用薬剤の世界市場見通し2023年-2029年(Assisted Reproduction Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

生殖補助医療用薬剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp